Peter Diamandis hosts the Moonshots podcast with a panel of 'mates.' He founded XPRIZE and Singularity University, sits on boards of Trust & Will and Vesmark, and runs the Future Vision XPRIZE for positive AI futures. He frames discussions around the 'singularity economy' and exponential technologies.
Insilico's Chemistry42 platform invented Rentosertib (Phase 3 for IPF) which shifted six protein aging clocks toward 3-6 years younger biology; peak effect at week 4 shows 3-4 years reversal per 4 weeks input — a spike of longevity escape velocity.
SpaceX is pursuing two pathways to $1T revenue: 1) Optimus/Tesla merger capturing physical labor economy, 2) TerraFab replacing TSMC/ASML as US domestic semiconductor leader in partnership with Nvidia, with Starlink as near-term cash engine funding orbital compute (Starmine) and massive fab buildout.
Science Corp's Prima retinal implant (ex-Neuralink president Max Hodak) achieved European approval for restoring central vision in macular degeneration, with patients gaining 5 lines on eye charts after 12 months, serving as revenue-generating Stage Zero for deeper BCI ambitions.